Transcriptomic Analysis to Identify Protective Dermal Papilla Signature in Occipital Scalp

April 2021 in “ Journal of Investigative Dermatology ”

Summik Limbu, Nilofer Farjo, Bessam Farjo, Paul Kemp, Claire A. Higgins

TLDR The research found genes that may protect certain scalp cells from hair loss.

The document presents a study that investigated the protective transcriptional signature of dermal papilla (DP) cells in the occipital (O) scalp, which are resistant to androgenetic alopecia (AGA), compared to the frontal (F) scalp where hair follicles are prone to miniaturization. The study involved transcriptomic profiling of patient-matched DP and dermal sheath (DS) cells from F and O hair follicles (HF) from 4 male patients undergoing hair transplantation surgery. The analysis identified 16 genes with significantly higher expression levels in the ODP compared to the other dermal cell types. These genes are believed to protect the ODP from size reduction and cell loss during the hair cycle, thus preventing miniaturization of OHF. The study also developed an animal-free model for high throughput analysis of inductivity, where ODP cells combined with epidermal keratinocytes self-organized into organoid structures. These organoids showed higher expression of the hair differentiation marker K75, indicating DP-induced keratinocyte reprogramming. The research aims to further assess how these ODP signature genes contribute to the protective role against AGA.

View this study on jidonline.org →

Discuss this study in the Community →

Related Community Posts Join

6 / 1000+ results

community COMPLETE OVERVIEW of the Treatment of androgenetic alopecia in men

29 upvotes 11 years ago

Male androgenetic alopecia is commonly treated with topical minoxidil and oral finasteride, both requiring continuous use. Other options include hair restoration surgery, dutasteride, light therapy, and camouflaging agents.

community If You Have DUPA, PLEASE READ THIS: Everyone Should Be Scalp Biopsied

in Research 830 upvotes 1 year ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community The Real Cause Of Androgenetic Alopecia

in Research/Science 677 upvotes 11 months ago

Androgenetic alopecia is caused by DHT affecting hair growth. Finasteride and minoxidil are used to manage hair loss by blocking DHT and promoting hair growth.

community Dht kills hair, but no one says why?

in Finasteride/Dutasteride 40 upvotes 2 weeks ago

DHT affects hair follicles, contributing to hair loss, but the exact mechanism is unclear. Treatments like finasteride and minoxidil are used to manage hair loss, though they may have side effects and varying effectiveness.

community 30-Min Dermatology Visit – Best Questions to Ask About Balding? ( 175$ )

in Treatment 6 upvotes 6 months ago

The conversation discusses hair loss treatments, focusing on finasteride, minoxidil, and other options like PRP and ketoconazole. It highlights the importance of asking specific questions during a dermatology visit to determine the cause of hair loss and appropriate treatments.

community Why is nobody studying the difference between donor and balding hair?

in Chat 89 upvotes 1 year ago

The conversation discusses why the difference between donor and balding hair isn't studied more to find a cure for hair loss. Treatments mentioned include Minoxidil, finasteride, and RU58841.

Related Research

7 / 7 results

research Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil

1 citations , August 2022 in “JAAD case reports”

Tofacitinib and oral minoxidil may help treat Sisaipho alopecia areata.

research Safety and Efficacy of Trimax-360 Serum in Healthy Adult Subjects with Mild to Moderate Alopecia of the Scalp

April 2022 in “Journal of Cosmetic Dermatology”

Trimax-360 Serum, when used for 98 days, safely and effectively improves hair growth, thickness, and density without any side effects.

research Significant Relationship Between Temporal Hair Loss and Other Scalp Areas in Female Pattern Hair Loss

5 citations , January 2020 in “Journal of Dermatology”

Temporal hair loss relates to overall scalp hair loss in women.

research Protection Against Chemotherapy-Induced Alopecia: Targeting ATP-Binding Cassette Transporters in the Hair Follicle

24 citations , November 2013 in “Trends in pharmacological sciences”

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.

research Pathobiology of Chemotherapy-Induced Hair Loss

218 citations , January 2013 in “The Lancet Oncology”

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

The Changing Patterns of Hair Density and Thickness in South Korean Women with Hair Loss: Clinical Office-Based Phototrichogram Analysis

research The Changing Patterns of Hair Density and Thickness in South Korean Women with Hair Loss: Clinical Office-Based Phototrichogram Analysis

41 citations , December 2008 in “International Journal of Dermatology”

South Korean women with hair loss have lower hair density and thickness compared to healthy women.

research Towards a Molecular Understanding of Hair Loss and Its Treatment

236 citations , July 2001 in “Trends in Molecular Medicine”

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.